LCA168 FOR GLIOBLASTOMA?

Glioblastoma is a formidable brain malignancy known for its fast growth and unresponsiveness to typical treatments. Studies are constantly underway to identify new therapeutic strategies, and recently, a read more novel biomarker named LCA168 has emerged as a potential avenue for glioblastoma treatment. LCA168 is a protein that is highly expressed